Introduction
otic lesion to calcify could be the accumulation of necrotic foam cells that would serve as a nidus for calcification, i.e. hydroxyapatite formation [6 ] . Indeed, Vascular calcification occurs frequently in atherosclernecrotic cells generally release high concentrations of otic lesions. In addition, several inherited diseases have mitochondrial phosphate and also display crystalbeen described that are characterized by isolated medial nucleating phosphatidylserine molecules that are usucalcification of arteries. The existence of such diseases, ally not found on the cell surface [7, 8] . Thus, the together with some recently developed mouse models, microenvironment of an atherosclerotic lesion may be indicates that vascular calcification and atherosclerosis a perfect setting for calcification to take place. are different genetic entities that can be studied separately. Our understanding of the genetic basis of vascular calcification has significantly increased after mouse genetics became available. The generation of two Vascular calcification in the absence of mutant mouse strains, i.e. mice lacking matrix GLA atherosclerosis protein or osteoprotegerin, has had the biggest impact on vascular calcification as both strains display isolated In humans several diseases have been described that medial calcification of arteries. These phenotypes demare characterized by isolated medial calcification of onstrate that vascular calcification is mostly a passive arteries [9] [10] [11] . Although the genetic basis has not process and that its inhibition is genetically controlled. been defined for any of these diseases, their existence indicates that atherosclerosis and vascular calcification are separate genetic entities. This has also been con-
Calcification of atherosclerotic lesions
firmed by mouse genetics. First, the analysis of a genetic cross between several inbred and genetically Atherosclerosis is the major cause of mortality in the engineered mouse strains showed that there is no Western hemisphere [1] . It is characterized by the co-segregation of arterial calcification and atherosclerpresence of atherosclerotic lesions in the arterial intima otic lesion development [12] . Second, in mouse models leading to narrowing of the vessels. The genetic basis of atherosclerosis, e.g. mice lacking apolipoprotein E underlying the formation of atherosclerotic lesions has or low-density lipoprotein receptor, calcification of been uncovered recently, mostly through the use of atherosclerotic lesions is a rare and probably secondary mouse genetics [2] . It involves a defective metabolism event [13] [14] [15] [16] . Third, at least two mutant mouse of lipoprotein particles that initially leads to the formastrains, e.g. mice deficient in osteoprotegerin or matrix tion of a fatty streak lesion characterized by the GLA protein, display arterial calcification in the presence of lipid-filled macrophages (foam cells) in the absence of atherosclerosis [17, 18] . subendothelium. This stage is followed by the accumu-In addition to these types of medial calcification in lation of lipid and eventually by fibrosis and thrommice and humans, there are rare cases of ectopic bone bosis. In humans, calcification is found in the majority formation inside the vessel wall [5] . By definition, bone of advanced atherosclerotic lesions. It is considered to formation is not simply mineralization. It requires that contribute to the overall morbidity of atherosclerosis cells of the vessel wall gain osteoblast-like characterby decreasing the elasticity of the vessels [3] .
istics and produce a bone matrix. This matrix needs For now it is unclear why atherosclerotic lesions to be subsequently resorbed by osteoclast-like cells have a tendency to calcify. The high frequency of leading to the formation of bone marrow. Cases of atherosclerotic calcification has led to the hypothesis ectopic bone formation in human arteries are too rare that it may be an active, even beneficial process [4] . to be understood genetically. However, one recent mouse model indicates that ectopic bone formation Mice lacking Smad6, an inhibitory molecule in the TGF-b signalling pathway, have various defects of the Inhibition of mineralization is genetically cardiovascular system including bone formation in the controlled media of the outflow tracts of the heart [19] . The underlying molecular mechanisms and the physiologi-The finding that mineralization needs to be inhibited cal relevance of this finding need to be further in arteries raises the question if the same is true for investigated. other tissues. Although ectopic calcification has been described in many tissues other than arteries, only one of them has been clearly demonstrated to require active Matrix GLA protein and osteoprotegerin are inhibition of mineralization. This tissue is cartilage, required to prevent calcification of mouse arteries and again it is the presence of Mgp that prevents spontaneous mineralization [18, 20] . The ECM of car-Matrix GLA protein (Mgp) is a c-carboxylated mintilage is different from the ECM of the arterial media eral-binding extracellular matrix ( ECM ) protein. In suggesting that inhibition of mineralization is a general mice its expression is restricted to two cell types: mechanism, and that in other tissues, where Mgp is vascular smooth muscle cells and chondrocytes [18] . not expressed, other inhibitors of mineralization have As demonstrated by a classical knockout experiment, to exist. In fact, this would not be surprising, given Mgp acts in vivo as an inhibitor of mineralization in the fact that extracellular fluids are supersaturated with arteries and cartilage [18] . Mice deficient in Mgp are calcium and phosphate [23] . normal at birth, but develop severe calcification of all What does this mean for physiological mineraliztheir arteries within weeks. This calcification is lethal ation? So far there is still no explanation for the fact with a 100% penetrance in different genetic backthat the skeletal matrix is the only ECM that mineralgrounds, and all Mgp-deficient mice die at around 8 izes. In addition, it is not clear yet if bone mineralizweeks of age, mostly due to rupture of the aorta [18] . ation is an active process, i.e. if osteoblasts produce Cartilage calcification also occurs in Mgp-deficient bone-specific ECM proteins that are required to induce mice showing that not only in arteries mineralization mineralization. The phenotype of the Mgp-deficient of the ECM needs to be inhibited. Histologically, the mice raises the hypothesis that bone mineralization arterial calcification in Mgp-deficient mice appears in may be a passive process, explained, at least in part, the media and, once initiated, advances rapidly along by the absence of inhibitors of mineralization from the elastin fibres. There is no indication of atherosclerotic bone matrix. In this respect it is important to state lesions or ectopic bone formation in these mice [18] .
that Mgp is not expressed by osteoblasts [18] . Future The phenotype of the Mgp-deficient mice is very experiments will determine if indeed the absence of informative. It demonstrates that vascular calcification Mgp and possibly of other inhibitors of mineralization is a process that would occur spontaneously if it would in bone is a factor favouring bone mineralization. not be actively inhibited. Clearly, in mice Mgp is the major molecule ensuring that arteries do not become calcified. Surprisingly however, this does not seem to Although calcification is most common in atheroscler-their ECM, but that other proteins acting in a similar fashion participate in the inhibition of mineralization. otic lesions, we know now that the genetic basis of vascular calcification is different from the one under-Indeed, several mineral-binding proteins have been localized to calcifying atherosclerotic lesions [21, 22] . lying the formation of atherosclerotic lesions. Thus, the calcification aspect of atherosclerosis can and Their involvement in regulating arterial calcification in humans needs further investigation.
Concluding remarks
should be studied separately and may one day also be treated separately. Another molecule preventing arterial calcification in mice is osteoprotegerin (Opg). Opg is a secreted TNF-
The second and even more important information comes mostly from the knockout of Mgp: vascular receptor-like molecule that acts as an inhibitor of terminal differentiation of bone-resorbing osteoclasts. calcification is a passive process that requires active inhibition. Mgp is the molecule that is responsible for Thus, Opg-deficient mice develop severe osteoporosis caused by increased bone resorption. In addition to this inhibition in mice. Although the importance of Mgp to prevent arterial calcification in humans has this phenotype, Opg-deficient mice display calcification of the aorta and renal arteries [17] . Compared to the not been clearly established yet, theoretically it seems that up-regulating Mgp expression in human arteries Mgp-deficient mice this calcification is rather mild and does not affect all arteries. Unlike Mgp, Opg does not could be beneficial to prevent atherosclerotic calcification. In addition to Mgp, it is likely that other inhib-contain domains that are likely to mediate mineralbinding properties. Thus, the mechanism of Opg action itors of mineralization act in human arteries. Once identified, these molecules will also be good targets for to prevent arterial calcification in mice, as well as its function in human arteries are for now unknown. future therapeutic approaches. mination of arterial calcification. Arterioscler Thromb 1994; 14:
